{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:02:41Z","timestamp":1784563361572,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mitochondrial ATP synthase catalyzes the coupling of oxidative phosphorylation. Under pathological conditions, ATP synthase hydrolyzes ATP to replenish protons from the matrix into the intermembrane space, sustaining mitochondrial membrane potential. ATPase inhibitory factor 1 (IF1) is a nuclear-encoded, ATP synthase-interacting protein that selectively inhibits the hydrolysis activity of ATP synthase, which may render the protective role of IF1 in ischemic hearts. However, the <jats:italic>in vivo<\/jats:italic> cardiac function of IF1 and the potential therapeutic application targeting IF1 remain obscure. In the present study, we uncovered that IF1 is upregulated in mouse hearts with pressure overload-induced hypertrophy and in human hearts with dilated cardiomyopathy. IF1 knockout (KO) mice were protected against cardiac dysfunction and pathological development induced by transverse aortic constriction (TAC) or isoproterenol infusion. The reduced ATP hydrolysis activated AMPK activity in IF1 KO hearts, which together facilitated autophagy. These results suggest that IF1 upregulation in the failing heart may be a maladaptive response. Inhibiting IF1 in the hypertrophied heart not only prevents cell death from excessive mitochondrial depolarization but also activates AMPK signaling and increases autophagy. Therefore, IF1 inhibition may serve as a potential therapeutic target in treating pathological cardiac hypertrophy and heart failure.<\/jats:p>","DOI":"10.1038\/s41598-017-11251-8","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T11:23:13Z","timestamp":1504092193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy"],"prefix":"10.1038","volume":"7","author":[{"given":"Kevin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-8535","authenticated-orcid":false,"given":"Qinqiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalamma","family":"Saja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Pogwizd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-8442","authenticated-orcid":false,"given":"Lufang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masasuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"11251_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circulation research \n                           113, 646\u2013659 (2013).","journal-title":"Circulation research"},{"key":"11251_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.1432-1327.1999.00350.x","volume":"262","author":"RD Appleby","year":"1999","unstructured":"Appleby, R. D. et al. Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. Eur J Biochem \n                           262, 108\u2013116 (1999).","journal-title":"Eur J Biochem"},{"key":"11251_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.4161\/auto.25413","volume":"9","author":"V Lefebvre","year":"2013","unstructured":"Lefebvre, V. et al. Genome-wide RNAi screen identifies ATPase inhibitory factor 1 (ATPIF1) as essential for PARK2 recruitment and mitophagy. Autophagy \n                           9, 1770\u20131779 (2013).","journal-title":"Autophagy"},{"key":"11251_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/370621a0","volume":"370","author":"JP Abrahams","year":"1994","unstructured":"Abrahams, J. P., Leslie, A. G., Lutter, R. & Walker, J. E. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. Nature \n                           370, 621\u2013628 (1994).","journal-title":"Nature"},{"key":"11251_CR5","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.1073\/pnas.93.14.6913","volume":"93","author":"MJ van Raaij","year":"1996","unstructured":"van Raaij, M. J., Abrahams, J. P., Leslie, A. G. & Walker, J. E. The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B. Proceedings of the National Academy of Sciences of the United States of America \n                           93, 6913\u20136917 (1996).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11251_CR6","doi-asserted-by":"publisher","first-page":"31761","DOI":"10.1074\/jbc.M401353200","volume":"279","author":"C Chen","year":"2004","unstructured":"Chen, C. et al. Mitochondrial ATP synthasome: three-dimensional structure by electron microscopy of the ATP synthase in complex formation with carriers for Pi and ADP\/ATP. The Journal of biological chemistry \n                           279, 31761\u201331768 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"11251_CR7","doi-asserted-by":"publisher","first-page":"13777","DOI":"10.1074\/jbc.M513369200","volume":"281","author":"C Chen","year":"2006","unstructured":"Chen, C. et al. Mitochondrial ATP synthase. Crystal structure of the catalytic F1 unit in a vanadate-induced transition-like state and implications for mechanism. The Journal of biological chemistry \n                           281, 13777\u201313783 (2006).","journal-title":"The Journal of biological chemistry"},{"key":"11251_CR8","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/S0021-9258(19)75338-1","volume":"238","author":"ME Pullman","year":"1963","unstructured":"Pullman, M. E. & Monroy, G. C. A Naturally Occurring Inhibitor of Mitochondrial Adenosine Triphosphatase. The Journal of biological chemistry \n                           238, 3762\u20133769 (1963).","journal-title":"The Journal of biological chemistry"},{"key":"11251_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.tibs.2009.03.006","volume":"34","author":"M Campanella","year":"2009","unstructured":"Campanella, M., Parker, N., Tan, C. H., Hall, A. M. & Duchen, M. R. IF(1): setting the pace of the F(1)F(o)-ATP synthase. Trends Biochem Sci \n                           34, 343\u2013350 (2009).","journal-title":"Trends Biochem Sci"},{"key":"11251_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0022-2828(87)80374-7","volume":"19","author":"W Rouslin","year":"1987","unstructured":"Rouslin, W. & Pullman, M. E. Protonic inhibition of the mitochondrial adenosine 5\u2019-triphosphatase in ischemic cardiac muscle. Reversible binding of the ATPase inhibitor protein to the mitochondrial ATPase during ischemia. Journal of molecular and cellular cardiology \n                           19, 661\u2013668 (1987).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"11251_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1006\/bbrc.1993.1997","volume":"194","author":"JF Sah","year":"1993","unstructured":"Sah, J. F., Kumar, C. & Mohanty, P. pH dependent conformational changes modulate functional activity of the mitochondrial ATPase inhibitor protein. Biochem Biophys Res Commun \n                           194, 1521\u20131528 (1993).","journal-title":"Biochem Biophys Res Commun"},{"key":"11251_CR12","doi-asserted-by":"publisher","first-page":"18781","DOI":"10.1074\/jbc.M112.345793","volume":"287","author":"M Fujikawa","year":"2012","unstructured":"Fujikawa, M., Imamura, H., Nakamura, J. & Yoshida, M. Assessing Actual Contribution of IF1, Inhibitor of Mitochondrial FoF1, to ATP Homeostasis, Cell Growth, Mitochondrial Morphology, and Cell Viability. The Journal of biological chemistry \n                           287, 18781\u201318787 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"11251_CR13","doi-asserted-by":"publisher","first-page":"H1747","DOI":"10.1152\/ajpheart.01019.2003","volume":"287","author":"GJ Grover","year":"2004","unstructured":"Grover, G. J. et al. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol \n                           287, H1747\u20131755 (2004).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"11251_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1755-5922.2008.00065.x","volume":"26","author":"GJ Grover","year":"2008","unstructured":"Grover, G. J. & Malm, J. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Cardiovasc Ther \n                           26, 287\u2013296 (2008).","journal-title":"Cardiovasc Ther"},{"key":"11251_CR15","doi-asserted-by":"crossref","unstructured":"Formentini, L. et al. In vivo inhibition of the mitochondrial H\u2009+\u2009-ATP synthase in neurons promotes metabolic preconditioning. EMBO J, (2014).","DOI":"10.1002\/embj.201386392"},{"key":"11251_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature11536","volume":"491","author":"DI Shah","year":"2012","unstructured":"Shah, D. I. et al. Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature \n                           491, 608\u2013612 (2012).","journal-title":"Nature"},{"key":"11251_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.celrep.2014.02.046","volume":"7","author":"WW Chen","year":"2014","unstructured":"Chen, W. W. et al. Inhibition of ATPIF1 Ameliorates Severe Mitochondrial Respiratory Chain Dysfunction in Mammalian Cells. Cell reports \n                           7, 27\u201334 (2014).","journal-title":"Cell reports"},{"key":"11251_CR18","doi-asserted-by":"crossref","unstructured":"Nakamura, J., Fujikawa, M. & Yoshida, M. IF1, a natural inhibitor of mitochondrial ATP synthase, is not essential for the normal growth and breeding of mice. Biosci Rep \n                           33, (2013).","DOI":"10.1042\/BSR20130078"},{"key":"11251_CR19","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.1073\/pnas.0707326104","volume":"104","author":"JR Gledhill","year":"2007","unstructured":"Gledhill, J. R., Montgomery, M. G., Leslie, A. G. & Walker, J. E. How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proceedings of the National Academy of Sciences of the United States of America \n                           104, 15671\u201315676 (2007).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11251_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2008.06.001","volume":"8","author":"M Campanella","year":"2008","unstructured":"Campanella, M. et al. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell metabolism \n                           8, 13\u201325 (2008).","journal-title":"Cell metabolism"},{"key":"11251_CR21","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.biocel.2008.06.013","volume":"40","author":"GJ Grover","year":"2008","unstructured":"Grover, G. J., Marone, P. A., Koetzner, L. & Seto-Young, D. Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease. The International Journal of Biochemistry & Cell Biology \n                           40, 2698\u20132701 (2008).","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"11251_CR22","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/hep.27312","volume":"60","author":"R Song","year":"2014","unstructured":"Song, R. et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology \n                           60, 1659\u20131673 (2014).","journal-title":"Hepatology"},{"key":"11251_CR23","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell, N. H. et al. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America \n                           98, 6668\u20136673 (2001).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11251_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0008-6363(02)00723-X","volume":"57","author":"S Frantz","year":"2003","unstructured":"Frantz, S. et al. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res \n                           57, 749\u2013756 (2003).","journal-title":"Cardiovasc Res"},{"key":"11251_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.celrep.2015.08.052","volume":"12","author":"J Garcia-Bermudez","year":"2015","unstructured":"Garcia-Bermudez, J. et al. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase. Cell reports \n                           12, 2143\u20132155 (2015).","journal-title":"Cell reports"},{"key":"11251_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/0022-2828(91)90185-O","volume":"23","author":"RB Jennings","year":"1991","unstructured":"Jennings, R. B., Reimer, K. A. & Steenbergen, C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. Journal of molecular and cellular cardiology \n                           23, 1383\u20131395 (1991).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"11251_CR27","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.celrep.2017.01.070","volume":"18","author":"D Faccenda","year":"2017","unstructured":"Faccenda, D. et al. Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1. Cell reports \n                           18, 1869\u20131883 (2017).","journal-title":"Cell reports"},{"key":"11251_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology \n                           13, 132\u2013141 (2011).","journal-title":"Nature cell biology"},{"key":"11251_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy \n                           12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"11251_CR30","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","volume":"126","author":"L He","year":"2012","unstructured":"He, L. et al. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation \n                           126, 1705\u20131716 (2012).","journal-title":"Circulation"},{"key":"11251_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/jmcc.2000.1276","volume":"33","author":"PS Brookes","year":"2001","unstructured":"Brookes, P. S. et al. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. Journal of molecular and cellular cardiology \n                           33, 69\u201382 (2001).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"11251_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1074\/mcp.M700076-MCP200","volume":"6","author":"I Wittig","year":"2007","unstructured":"Wittig, I., Karas, M. & Schagger, H. High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes. Mol Cell Proteomics \n                           6, 1215\u20131225 (2007).","journal-title":"Mol Cell Proteomics"},{"key":"11251_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCRESAHA.109.206185","volume":"106","author":"P Wang","year":"2010","unstructured":"Wang, P. et al. Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart. Circulation research \n                           106, 911\u2013919 (2010).","journal-title":"Circulation research"},{"key":"11251_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/HYPERTENSIONAHA.110.164590","volume":"57","author":"J Liu","year":"2011","unstructured":"Liu, J. et al. Peroxisome Proliferator-Activated Receptor {beta}\/{delta} Activation in Adult Hearts Facilitates Mitochondrial Function and Cardiac Performance Under Pressure-Overload Condition. Hypertension \n                           57, 223\u2013230 (2011).","journal-title":"Hypertension"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11251-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:18:27Z","timestamp":1671790707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11251"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11251-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]},"assertion":[{"value":"26 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10501"}}